Follicular DCs (FDCs) reside in primary B cell follicles and germinal centers (GCs) ( 1 ) . FDCs retain native immune complexes with complement and Fc ␥ receptors ( 2 ) , and display them to B cells, which they embrace with intricate dendritic networks. This is thought to facilitate the GC reactions, and the selection of B cells that gives rise to high-affi nity antibodies ( 3 ) and long-term memory B cells ( 4 ) . But others ( 5 ) have questioned the importance of FDCs because primary immune responses, affi nity maturation, and memory B cells arise in mice engineered to lack the retention of immune complexes by FDCs ( 6 ) , and even in Lta Ϫ / Ϫ mice that are defi cient in lymphotoxin (LT) signaling and lack FDCs completely ( 7 ) . Hence, the functional contribution of FDCs to affi nity maturation remains unclear.
Some biomarkers, including the complement receptors CD21/35 and the complement factor C4 ( 8 ) , allow for FDC immunodetection in vivo, yet none of them are exclusively restricted to FDCs. A more specifi c marker is hybridoma clone 4C11, whose reactivity is confi ned to FDCs and tingible-body macrophages (TBM s) ( 9 ) . The antigen recognized by 4C11 was provisionally termed FDC-M1, but its identity has remained unknown.
Phagocytosis of apoptotic GC B cells, the remnants of which are recognizable as tingible bodies inside TBM s, is thought to be a crucial function of TBM s. Apoptotic cells are engulfed upon opsonization by milk fat globule epidermal growth factor (EGF) 8 (Mfge8) ( 10 ) , which binds bifunctionally to phosphatidylserine on apoptotic cells and to integrins expressed by phagocytes ( 11 ) . Originally identifi ed as a membrane component of milk-fat globules ( 12 ) , Mfge8 was reported to be expressed by various phagocytes, including TBM s, activated peritoneal macrophages (PM s), and immature DCs ( 10, 11 ) .
Mfge8 Ϫ / Ϫ mice suff er from impaired engulfment of GC B cell corpses by TBM s. Consequently, their TBM s carry supernumerary nonengulfed apoptotic B cells, which cause action of 4C11 with immobilized rMfge8 was observed over several serial injections until binding had reached saturation ( Fig. 1 D , I ). When anti-Mfge8 antibody 2422 was subsequently injected, its binding was minimal ( Fig. 1 D , I , arrow, 2422), suggesting that 4C11 interfered with the binding of 2422 to rMfge8. Binding of anti-Mfge8 antibody 18A2-G10, in contrast, was not aff ected ( Fig. 1 D , I , arrow, 18A2-G10). Rat IgG2c did not interact with immobilized rMfge8 (not depicted).
Antibodies were then reinjected in a diff erent order. First, 2422 was added until saturation was reached ( Fig. 1 D , II) . 4C11 was injected, yet it did not bind to rMfge8 ( Fig. 1 D , II, arrow, 4C11). In contrast, 18A2-G10 always bound to rMfge8, even in the presence of previously bound 2422 or 4C11 ( Fig. 1 D, I and II) . Hence, the 18A2-G10 epitope is distinct from those of the other two antibodies. These results indicate that 4C11 and 2422 abrogate each other ' s binding to Mfge8, either because they share a common or overlapping epitope, or because they sterically hinder each other. This was confi rmed by the next experiment: immobilized 18A2-G10 was used to capture rMfge8. Then, the antibodies 18A2-G10, 2422, and 4C11 were added in a sandwich design. Under these conditions, injected 18A2-G10 did not bind to surfaces decorated with 18A2-G10 -captured rMfge8, confi rming that 18A2-G10 binds to a single epitope on Mfge8 ( Fig. 1 D , III) . Subsequent injection of 4C11 resulted in a strong interaction with captured rMfge8. When 2422 was applied, no binding occurred. We then reversed the order of injections: 2422 was added before 4C11. In this case, the fi rst antibody, 2422, interacted with 18A2-G10 -captured rMfge8, whereas 4C11 did not ( Fig. 1 D , IV) .
These data show that the FDC-M1 antigen identifi ed by antibody 4C11 is Mfge8. The molecular identifi cation of FDC-M1 expands the arsenal of tools for functional and morphological studies of FDCs in many ways. Because Mfge8 is secreted, its histological assignment by RNA in situ hybridization (ISH) is more informative of its cellular origin than immunohistology and will help defi ne the precise histogenesis of FDCs. Also, we found that anti-Mfge8 antibody 18A2-G10 labels FDCs on formalin-fi xed, paraffi n-embedded tissue (unpublished data), thereby enabling the recognition of FDCs in archived tissue.
FDCs are the major source of Mfge8 in the spleen
The fi nding that Mfge8 is detected in TBM s within splenic follicles ( 10 ) may be compatible with the above results if Mfge8 were secreted by FDCs and trapped by TBM s. We tested this proposition in reciprocal BM chimeras between Mfge8 Ϫ / Ϫ and WT mice. FDCs are stromal and radioresistant, whereas TBM s are mononuclear phagocytes of hematopoietic origin and are thought to be radiosensitive ( 14 ) . To provide an independent histogenetic marker, lethally irradiated Mfge8 Ϫ / Ϫ mice expressing the CD45.2 allelic variant were reconstituted with BM from CD45.1 congenic WT mice, and vice versa.
The mean reconstitution effi ciency determined by FACS analysis of peripheral blood was 93.8 ± 3.6% (unpublished them to appear enlarged. This defect is associated with systemic lupus erythematosus (SLE) and autoimmune glomerulonephritis ( 10 ) . In this report, we provide conclusive evidence that the FDC-M1 antigen identifi ed by clone 4C11 is identical to Mfge8, that FDCs are the only source of splenic Mfge8, and that TBM s only acquire surface Mfge8 if situated in the proximity of Mfge8 -expressing FDCs or in lymph nodes that drain exogenous Mfge8. The absence of FDCs in mice lacking LTs or their receptors correlated with the profound depletion of splenic Mfge8 in LT-defi cient mice, suggesting that impairment of FDC homeostasis contributes to their autoimmune pathologies.
RESULTS AND DISCUSSION FDC-M1 and Mfge8 are identical
The present report originated from our serendipitous observation that FDC-M1 + networks were completely absent from splenic cryosections of Mfge8 Ϫ / Ϫ mice stained with anti -FDC-M1 antibody 4C11 (Fig. S1 , available at http://www.jem .org/cgi/content/full/jem.20071019/DC1). This was unexpected, because no FDC abnormalities had been reported in Mfge8 Ϫ / Ϫ mice despite progressive splenomegaly, enlarged splenic TBM s, and hyperplastic follicles with increased numbers of peanut agglutinin -positive (PNA + ) GCs ( 10 ) . The absence of 4C11 immunoreactivity in Mfge8 Ϫ / Ϫ spleens did not result from an absence of mature FDCs, because FDC networks were easily identifi able by CD21/35 immunostains (Fig. S1) .
The anti-Mfge8 antibodies 18A2-G10 and 2422 ( 11 ) identifi ed FDC networks and colocalized with 4C11 immunostains ( Fig. 1 A ) . We therefore considered the possibility that FDC-M1 and Mfge8 are the same antigen. Indeed, preincubation with excess rMfge8, but not with rEGF or recombinant prion protein (rPrP), inhibited the binding of both 18A2-G10 and 4C11 to FDC networks. The presence of FDCs in these sections was independently confi rmed by PrP C -specifi c immunolabeling, which is abundantly expressed by FDCs ( 13 ) ( Fig. 1 B ) .
We then assessed whether anti -FDC-M1 antibody 4C11 immunoprecipitates Mfge8. Paramagnetic beads were conjugated to immunoaffi nity-purifi ed antibodies 4C11, anti-Mfge8 antibody 2422, or rat IgG2c isotype control antibody. Beads were incubated with protein extracts from WT or Mfge8 Ϫ / Ϫ spleens, and precipitated proteins were analyzed by Western blotting with anti-Mfge8 antibody 18A2-G10. After immunoprecipitation with anti-Mfge8 antibodies, two bands with molecular masses of ‫ف‬ 45 and 55 kD were detected ( Fig. 1 C ) . After immunoprecipitation with anti -FDC-M1 beads, two signals were obtained with molecular masses matching those of the 2422 immunoprecipitation ( Fig. 1 C ) . Both signals were absent in spleens from Mfge8 Ϫ / Ϫ mice, confi rming their identity as genuine Mfge8.
We next verifi ed the interaction of rMfge8 with anti -FDC-M1 antibody 4C11 by surface plasmon resonance (SPR). 4C11 was injected onto Biacore sensor chip surfaces covalently coated with rMfge8 or, for control, rPrP. Inter-
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stains of Mfge8 Ϫ / Ϫ → Mfge8 Ϫ / Ϫ (all CD45.2 + ) and WT → WT (all CD45.1 + ) spleens confi rmed the absence of cross-reactivity (Fig. S2) . Two-color immunolabeling of Mfge8 Ϫ / Ϫ → WT spleens with antibodies against CD68 (cyan) and CD45.1 (red) confi rmed that TBM s were not host derived, whereas TBM s of WT → Mfge8 Ϫ / Ϫ spleens did not express CD45.2 (Fig. S2) . data). The donor origin of TBM s was confi rmed by multicolor immunofl uorescence with antibodies against CD45.1, CD45.2, and CD68 in > 50 follicles of fi ve mice per group. The results ruled out the possibility that host-derived TBM s may have survived irradiation ( a stromal origin ( 14, 16 ) . Indeed, Ptprc , which encodes CD45, was markedly reduced in MACS-enriched FDC clusters ( 17 ) , whereas Mfge8 and Cxcl13 (a B cell -attracting chemokine expressed by FDCs; reference 18 ) were increased Therefore, in all chimeras the overwhelming majority of TBM s always originated from donor BM.
Early analyses of BM chimeras suggested a hematopoietic derivation of FDCs ( 15 ), but most current evidence favors BM-chimeric mice were immunized and boosted with OVA/alum to induce GCs before analysis. 9 wk after reconstitution, splenic Mfge8 and CD68 expression were analyzed immunohistochemically. Surprisingly, Mfge8 Ϫ / Ϫ mice that had received WT BM (WT → Mfge8 Ϫ / Ϫ ) completely lacked splenic Mfge8 immunoreactivity. Not only radioresistant FDCs but also BM-derived CD68 + TBM s were phenotypically Mfge8 negative ( Fig. 2 A , top) although they had clearly originated from Mfge8 +/+ donors (Fig. S2 ). In contrast, spleens of WT mice reconstituted with Mfge8 Ϫ / Ϫ BM ( Mfge8 Ϫ / Ϫ → WT) contained not only Mfge8 + FDCs but also phenotypically Mfge8-positive TBM s originating from Mfge8 Ϫ / Ϫ donors ( Fig. 2 A ) . Irrespective of their genotype, therefore, TBM s were always Mfge8 + whenever FDCs expressed Mfge8, yet they were always Mfge8 Ϫ whenever FDCs lacked Mfge8.
We then determined the transcriptional patterns of splenic Mfge8 by RNA ISH. In WT → WT mice, Mfge8 transcription was restricted to follicles ( Fig. 2 B ) and was strongest in GCs, where FDCs reside. Some Mfge8 + cells were found in the periphery of follicles. These cells were radioresistant and may represent immature FDC precursor cells ( 19 ) . Overall, the ISH visualized more Mfge8 + cells than 4C11 immunohistochemistry, probably owing to the higher sensitivity of the former.
Consecutive sections were immunostained with 4C11 and anti-CD68 antibodies. In this case, both Mfge8 immunostains and Mfge8 ISH visualized characteristic FDC networks, confi rming that Mfge8 is indeed produced by FDCs rather than being secreted by other cell types and taken up by FDCs ( Fig. 2 B ) . No ISH signal was detected on Mfge8 Ϫ / Ϫ → Mfge8 Ϫ / Ϫ chimeric spleens, confi rming the specifi city of the Mfge8 in situ riboprobe ( Fig. 2 B ) .
The Mfge8 expression pattern in Mfge8 Ϫ / Ϫ → WT chimeras was identical to that of WT mice, whereas Mfge8 expression was completely absent from WT → Mfge8 Ϫ / Ϫ chimeras ( Fig. 2 B ) . Therefore, radioresistant cells including FDCs, rather than radiosensitive cells including TBM s, are the source of Mfge8 in the spleen. Mfge8 expression in WT → Mfge8 Ϫ / Ϫ chimeric spleens was below detectability by quantitative RT-PCR ( < 0.25% WT splenocyte RNA spiked into Mfge8 Ϫ / Ϫ splenocyte RNA; not depicted), whereas Mfge8 Ϫ / Ϫ → WT spleens showed expression levels similar to WT → WT spleens (Fig.  S4 A, available at http://www.jem.org/cgi/content/full/ jem.20071019/DC1).
We then searched for Mfge8 transcripts within CD68 + macrophages by combining fl uorescent ISH (green) with CD68 immunofl uorescence stains on individual cryosections (Fig. S4 B) . In immunized WT spleens, none of the CD68 + TBM s (white arrows) colocalized with the green Mfge8 ISH signal, which was absent in the Mfge8 Ϫ / Ϫ spleens. Conversely, all cells showing Mfge8 transcripts were negative in the CD68 immunostaining (Fig. S4 B, yellow arrows) . Hence, FDCs but not TBM s transcribe Mfge8 .
PM s express Mfge8 only upon stimulation PM s were previously found to express Mfge8 upon stimulation with thioglycollate ( 11 ) . We analyzed Mfge8 expression in stimulated PM s isolated from BM chimeras. Mfge8 expression was only detectable in PM s from WT → WT and WT → Mfge8 Ϫ / Ϫ chimeras but not in those of Mfge8 Ϫ / Ϫ → WT and Mfge8 Ϫ / Ϫ → Mfge8 Ϫ / Ϫ chimeras, and was only detectable in stimulated but not in unstimulated cells (Fig. S5 , available at http://www.jem.org/cgi/content/full/jem.20071019/DC1). These results confi rm that extralymphatic PM s do not express Mfge8 under normal conditions but only after stimulation ( 11 ) .
Naive, nonimmunized mice displayed Mfge8 -expressing FDC networks, implying that FDCs express Mfge8 constitutively. In contrast, Mfge8 transcription by PM appears to be dependent on infl ammatory stimuli and was never detectable in vivo in TBM s, not even after immunization, when most TBM s are highly immunoreactive for secondarily acquired Mfge8 protein.
TBM s can acquire Mfge8 from extracellular sources
The above indicates that TBM s appear immunohistochemically Mfge8 + because they take up FDC-derived Mfge8, either before or during the ingestion of apoptotic B cells. To further challenge this hypothesis, 10 μ g rMfge8 or rPrP was injected into the footpads of Mfge8 Ϫ / Ϫ or Prnp o/o mice, respectively. 20 h later, the draining popliteal lymph nodes were collected and immunostained for Mfge8. Although no Mfge8 immunolabeling was observed in the contralateral lymph node after PBS injection ( Fig. 3 , middle) , Mfge8 was readily detectable in draining lymph nodes after Mfge8 injection. FDC networks, visualized by immunofl uorescence for the complement receptors CD21/35, were only weakly Mfge8 + ( Fig. 3 , left) , indicating that they trapped only small amounts of Mfge8. In contrast, CD68 + TBM s were strongly immunoreactive for Mfge8. No PrP immunoreactivity was observed in the draining lymph nodes of Prnp o/o mice 20h after injection ( Fig. 3 , right) , indicating that TBM s do not generically incorporate all soluble recombinant proteins. We conclude that Mfge8 is synthesized by FDCs, secreted, and eventually acquired by macrophages exposing appropriate receptors.
Lack of Mfge8 expression by FDCs impairs corpse engulfment
Mfge8 Ϫ / Ϫ mice suff er from splenomegaly and a phagocytosis defect of TBM s ( 10 ). We used BM chimeras to determine whether these phenotypes are caused by stromal or hematopoietic Mfge8 defi ciency. Only Mfge8 Ϫ / Ϫ → Mfge8 Ϫ / Ϫ and WT → Mfge8 Ϫ / Ϫ mice developed splenomegaly, with spleen weights approximately twice as high as those of WT → WT and Mfge8 Ϫ / Ϫ → WT mice (Fig. S6 , available at http://www.jem .org/cgi/content/full/jem.20071019/DC1). Therefore, the splenomegaly of aged Mfge8 Ϫ / Ϫ mice could be unambiguously ascribed to the lack of Mfge8 expression by stromal cells, cells per CD68 + TBM was determined in at least 13 PNA + GCs in each group of mice. TBM s of Mfge8 Ϫ / Ϫ → Mfge8 Ϫ / Ϫ and WT → WT mice were found to be associated with 6 ± 1.8 and 2.4 ± 0.5 TUNEL + cells, respectively. TBM s of WT → Mfge8 Ϫ / Ϫ mice were associated with signifi cantly more TUNEL + cells (5.8 ± 1.6) than TBM s of Mfge8 Ϫ / Ϫ → WT mice (2.5 ± 0.9; P < 0.0001; Fig. 4 A ) . We conclude that the apoptotic load of macrophages was increased whenever Mfge8 was absent from radioresistant stromal cells, supporting the contention that FDC-derived Mfge8 regulates the engulfment of apoptotic cells.
We found apoptotic lymphocytes in various degradation stages within TBM s of all chimeric mice, including ( Fig. 4 B ) . This points to the existence of hitherto unexplored, Mfge8-independent mechanisms of corpse removal and may explain why Mfge8 Ϫ / Ϫ mice only suff er from mild SLE. Complement factors may also be and could not be corrected by any putative hematopoietic Mfge8 expression.
Mfge8 Ϫ / Ϫ spleens were found to host enlarged TBM s, whose surfaces were loaded with nonengulfed apoptotic bodies ( 10 ) . In light of the above results, this phenotype may be attributed to the absence of FDC-produced Mfge8. We tested this possibility by quantifying the number of TdT-mediated dUTP-biotin nick-end labeling (TUNEL) -positive apoptotic cells associated with each TBM . We fi rst determined the mean number of TUNEL + cells associated with all macrophages within splenic white pulp follicles. Mfge8 Ϫ / Ϫ → Mfge8 Ϫ / Ϫ and WT → Mfge8 Ϫ / Ϫ chimeras displayed marginally increased numbers of macrophage-bound apoptotic cells over WT → WT and Mfge8 Ϫ / Ϫ → WT chimeras (unpublished data), but statistical signifi cance was not attained. We then performed the same analysis but counted only those macrophages that resided within PNA + GCs. The mean number of TUNEL + apoptotic ( 20 ) and C1q -ablated mice develop SLE ( 21 ) .
Effi cient degradation of apoptotic cells in splenic follicles depends on LT signaling
Because FDC development and maintenance require LT signaling, LTs may control Mfge8 availability and, consequently, removal of apoptotic cells from GCs. We tested This model predicates a functional interaction of two distinct cell types, FDCs and TBM s, in the removal of apoptotic cells from GCs. This is plausible for physiological and anatomical reasons. Apoptosis of GC B cells is very frequent, and their rapid and effi cient removal seems important to avoid autoimmunity. But the paucity of scavenging cells, TBM s, may limit the removal process. However, it would be wasteful for TBM s to produce both Mfge8 and its receptors, ␣ V ␤ 3 and ␣ V ␤ 5 integrins. Conversely, these data suggest a tunable mechanism, with FDCs establishing a gradient of Mfge8 availability within GCs. Through their strategic microanatomical positioning within follicles, FDCs arm TBM s for engulfment only in the vicinity of apoptotic B cells. Accordingly, the apoptotic body load was dramatically increased in macrophages residing within GCs. Because of their intimacy with GC B cells, FDCs may directly decorate negatively selected B cells with Mfge8 ( Fig. 5 ) . This two-tiered mechanism may help ensure that numerous dying cells are recognized and degraded by far fewer TBM s.
Lack of LT signaling, which results in the absence of FDCs, suppressed splenic Mfge8 expression, and combined TUNEL assays and CD68 immunostains indicated that the effi cient removal of apoptotic cells was also impaired. These fi ndings hint to a signaling hierarchy that is driven by LTs, enrolls LT ␤ Rdependent signaling within FDCs, and enables topographically controlled apoptotic cell removal within GCs.
Lta Ϫ / Ϫ , and Ltb Ϫ / Ϫ mice immunized with OVA ( Fig. 4 C ) . TBM s of WT mice contained tingible bodies identifi able as small TUNEL + particles inside TBM s ( Fig. 4 C , far left) . Small degraded TUNEL + bodies were also observed in Mfge8 Ϫ / Ϫ mice ( Fig. 4 C , second from the left) . In contrast, although Ltbr Ϫ / Ϫ follicles contained some CD68 + cells binding TUNEL + cells, the latter appeared largely intact, and the accumulation of small characteristic TUNEL + tingible bodies within TBM s was absent ( Fig. 4 C ) . Similar results were observed in mice devoid of LT ␣ or LT ␤ ( Fig. 4 C ) , confi rming a severe impairment of macrophage-mediated degradation of apoptotic cells in the GCs of all mice defective in LT signaling.
The realization that FDCs are the major source of Mfge8 in GCs points to a previously unrecognized role for these cells in GC homeostasis. In addition to modulating the survival of GC B cells, FDCs appear to regulate their removal once these cells have undergone apoptosis. These results indicate that FDCs provide Mfge8 to GCs, which then binds to phosphatidylserine on apoptotic B cells and targets them for removal by TBM s. This would explain why TBM s register as Mfge8 + upon ingestion of apoptotic B cells, and indeed, we were able to show that TBM s take up extracellular Mfge8 after subcutaneous injection of rMfge8 ( Fig. 3 ) . donor BM cells i.v. Reconstitution effi ciency was assed after 5 wk by FACS analysis of blood leukocytes. 6 wk after engraftment, mice were immunized i.p. with 100 μ g OVA (Sigma-Aldrich) in alum (Imject Alum; Thermo Fisher Scientifi c). 2 wk later, mice were boosted with the same dose of OVA.
RNA ISH. Digoxigenin (DIG)-labeled Mfge8 riboprobe was obtained by transcription of pBluescript II KS+ (Stratagene) containing the open reading frame of Mfge8 . ISH was performed on spleen cryosections. For fl uorescent ISH, sections were prestained with biotinylated anti-CD68 antibody and postfi xed in 4% paraformaldehyde, followed by acetylation. After prehybridization, 200 ng/ml of DIG-labeled RNA probe was added to the hybridization buff er and incubated at 72 ° C overnight. For detection, either anti-DIGalkaline phosphatase or anti-DIG -fl uorescein antibody with a fl uorescent enhancer kit (Roche) was used.
FDC cluster isolation and quantitative real-time PCR analysis. FDCs from lymph nodes were isolated as described previously ( 17 ) . FDCenriched and fl ow-through fractions were lysed in TRI zol . RNA was isolated and cDNA was synthesized. Quantitative real-time PCR was performed using the SYBR Green PCR Master Mix (QIAGEN) on a 7900HT Fast Real-Time PCR System (Applied Biosystems) using the default cycling conditions. Expression levels were normalized using Gapdh . The following primers were used: Gapdh forward primer, 5 Ј -CCACCCCAG-CAAGGAGACT-3 Ј ; Gapdh reverse primer, 5 Ј -GAAATTGTGAGGGA-GATGCT-3 Ј ; Mfge8 forward primer, 5 Ј -ATATGGGTTTCATGGGC-TTG-3 Ј ; Mfge8 reverse primer, 5 Ј -GAGGCTGTAAGCCACCTTGA-3 Ј ; Cxcl13 forward primer, 5 Ј -TCGTGCCAAATGGTTACAAA-3 Ј ; Cxcl13 reverse primer, 5 Ј -ACAAGGATGTGGGTTGGGTA-3 Ј ; Ptprc forward primer, 5 Ј -AAACGATCGGTGACTTTTGG-3 Ј ; and Ptprc reverse primer, 5 Ј -AGCTCTTCCCCTTTCCATGT-3 Ј .
Electron microscopy. Samples were fi xed in 2% glutaraldehyde in 0.1 M cacodylate buff er (pH 7.4), washed and postfi xed in a mixture of 1% OsO 4 and 1.5% K 4 Fe(CN) 6 in 0.1 M cacodylate buff er (pH 7.4), dehydrated, and embedded in Epon 812 (Fluka). The resin specimens were trimmed, and 70 -90-nm sections were cut. Ultrathin sections were collected on copper 6200 grids and contrasted with uranyl acetate and lead acetate before examination with a transmission electron microscope (CX 100 II; JEOL Ltd.).
Online supplemental material. Fig. S1 shows that Mfge8 Ϫ / Ϫ mice lack FDC-M1 + networks. Fig. S2 reveals that TBM s are donor derived. Fig. S3 depicts Ptprc expression as down-regulated in FDC-enriched clusters. Fig.  S4 shows that Mfge8 expression is absent in spleens with stromal Mfge8 defi ciency and that CD68 + TBM s do not contain Mfge8 RNA. An analysis of Mfge8 expression in PM s is depicted in Fig. S5 . Fig. S6 shows that stromal Mfge8 defi ciency causes splenomegaly. Ltbr Ϫ / Ϫ , Lta Ϫ / Ϫ , and Ltb Ϫ / Ϫ mice develop severe systemic autoimmunity with lymphocytic infi ltrates in multiple organs. Although this disease is more severe than that of Mfge8 Ϫ / Ϫ mice, the similarities are evident and include elevated levels of autoimmune antibodies and renal pathology ( 10, 24 ) . In LT-defi cient mice, this phenotype was originally attributed to decreased Aire expression in medullary thymic epithelial cells ( 24 ) . This view, however, was challenged by reports of unaltered frequencies of Aire + medullary thymic epithelial cells in Lta Ϫ / Ϫ mice ( 25 ) and unaltered Aire expression in Ltbr Ϫ / Ϫ mice ( 26, 27 ) . Our fi ndings suggest an alternative explanation for the autoimmunity in the latter mice. By depleting follicular Mfge8, LT signaling defects suppress the licensing activity that FDCs exert on TBM s and, in turn, impair corpse removal from GCs. Hence, FDCs may control housekeeping functions required for the operation of lymphoid organs and for avoiding autoimmune phenomena.
MATERIALS AND METHODS

Mice.
Mfge8 Ϫ / Ϫ mice were generated in the laboratory of S. Nagata (Kyoto University, Kyoto, Japan) and were bred on a (C57BL/6 × 129)F 1 mixed background ( 10 ) . Prnp o/o mice and Ltbr Ϫ / Ϫ , Lta Ϫ / Ϫ , and Ltb Ϫ / Ϫ mice were described previously ( 22, 28, 29 ) . C57BL/6-CD45.1 mice were obtained from Harlan Laboratories. All experiments were in accordance with Swiss federal legislation and were approved by local authorities.
Immunohistochemical analysis. Acetone-fi xed cryosections were blocked (0.5% BSA, 1% goat serum in PBS) and primary antibodies were added. Primary antibodies were 4C11 (NovImmune SA or BD Biosciences), 18A2-G10 (MBL International), 2422 (Qbiogene), anti-CD21/35, anti-CD45.2 -FITC, anti-CD45.1 -biotin (all from BD Biosciences), anti-CD68 (AbD Serotec), and anti-PrP antibody POM2-Cy5 (developed in our laboratory). For competition experiments, 18A2-G10 or 4C11 were preincubated with 25 μ g/ml rMfge8, rEGF (both from R & D Systems), or rPrP (produced in our laboratory). Sections were analyzed by fl uorescence microscopy (BX61; Olympus). TUNEL assays were performed with the ApopTaq Plus Fluorescein In Situ Apoptosis Detection Kit (Millipore) according to the manufacturer ' s instructions. Before TUNEL stainings, unfi xed sections were blocked and stained with biotinylated PNA (Vector Laboratories) and anti-CD68 antibodies, and then fi xed with paraformaldehyde. Quantitation of TUNEL + cells per macrophage was performed in a stringently blinded fashion. One scientist recorded micrographs of GCs, and a second scientist (blinded with respect to the genotypes of the mice) counted the number of apoptotic bodies per macrophage.
Immunoprecipitation and Western blotting. Paramagnetic beads (Dynabeads M280 Tosylactivated; Invitrogen) were conjugated with 4C11, 2422, or rat IgG2c isotype control antibody according to the manufacturer ' s manual and incubated with spleen homogenates. Immunoprecipitates were analyzed by Western blotting using anti-Mfge8 antibody 18A2-G10. For detection, goat anti -Armenian hamster IgG -horseradish peroxidase was used.
SPR. SPR was performed on a Biacore 3000 instrument (GE Healthcare). Antibodies or recombinant proteins were immobilized on fl ow cells of an activated CM5 chip (Biacore) to 10,000 and 15,000 response units, respectively. All recombinant proteins or antibodies were injected at a concentration of 50 μ g/ml diluted in HBS-EP buff er. The fl ow rate was 5 μ l/min. For control, all protein injections were made on two fl ow cells, where the fi rst fl ow cell was coated with control protein/antibody and the second was coated with the protein/antibody of interest.
BM chimeras. BM recipients were lethally irradiated (950 rad). Donor BM was isolated by fl ushing tibias and femurs. Recipient mice received 10 7
